By 
Acadia Healthcare (NASDAQ: ACHC), a leading provider of behavioral health services in the United States, has expanded its network with the acquisition of three opioid treatment centers in South Carolina. The newly acquired facilities—now rebranded as Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center—are part of Acadia’s Comprehensive Treatment Center (CTC) division, which focuses on delivering medication-assisted treatment (MAT) and counseling services to patients struggling with opioid addiction.
Addressing South Carolina’s Addiction Treatment Needs
The opioid crisis continues to impact communities across the country, and South Carolina is no exception. By acquiring these three treatment centers, Acadia Healthcare is addressing the urgent need for opioid treatment services in the state. South Carolina has been identified as an underserved region for addiction care, and these new facilities will offer a range of services designed to help individuals recover from opioid use disorder. Each center provides FDA-approved medications, such as methadone and buprenorphine, in combination with behavioral health therapies, ensuring that patients receive a comprehensive treatment approach.
Medication-assisted treatment, or MAT, is recognized as one of the most effective methods for treating opioid addiction. By combining medication with counseling and support services, patients are able to manage withdrawal symptoms and reduce their cravings while receiving the psychological care they need to achieve long-term recovery. Acadia Healthcare’s decision to expand its services into South Carolina will improve access to these life-saving treatments for thousands of individuals in need.
Acadia Healthcare’s National Growth Strategy
The acquisition of these South Carolina clinics is part of Acadia Healthcare’s broader strategy to expand its national footprint. Acadia, which operates 258 behavioral healthcare facilities across 38 states and Puerto Rico, has been focusing on growth through mergers and acquisitions as well as new facility openings. The company’s CTC division, in particular, has seen significant growth, with 165 locations across 33 states now offering opioid treatment services to more than 72,000 patients each day.
NASDAQ: ACHC has made it clear that addressing the opioid epidemic is a top priority. By acquiring facilities in underserved areas like South Carolina, Acadia Healthcare is positioning itself as a leader in addiction treatment while also meeting the growing demand for comprehensive behavioral healthcare services across the country.
Enhancing Behavioral Health Services in the Carolinas
This latest move into South Carolina follows Acadia Healthcare’s recent acquisition of three treatment centers in North Carolina earlier this year. The company’s focus on expanding its presence in the Carolinas reflects its commitment to addressing the needs of communities that have been severely affected by the opioid crisis. The newly acquired centers will be integrated into Acadia’s existing network of CTCs, allowing the company to offer a continuum of care that includes medical support, individual and group counseling, and other essential services.
By expanding its presence in the southeastern U.S., Acadia Healthcare is not only meeting the immediate needs of patients struggling with addiction but also building a foundation for long-term success in the region. The company plans to continue expanding its services, with 14 new CTCs expected to open by the end of 2024, further cementing its role as a key player in the fight against opioid addiction.
Comments